ReviewReviews in cardiovascular medicine2023

Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.

Agnese Maria Fioretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.